JRCT ID: jRCTs021200022
Registered date:01/10/2020
Safety and efficacy of adjuvants in vitrectomy
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Macular hole |
| Date of first enrollment | 01/10/2020 |
| Target sample size | 60 |
| Countries of recruitment | |
| Study type | Interventional |
| Intervention(s) | Vitrectomy with internal limiting membrane peeling using BBG, ICG and TA as surgical adjuvants |
Outcome(s)
| Primary Outcome | Displacement distance of retinal vessel determined by OCT angiography |
|---|---|
| Secondary Outcome | Association of macular displacement with changes in function determined by anorthopia and visual acuity, and morphology determined by retinal and choroidal thickness |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | Cases with macular hole |
| Exclude criteria | Cases who have vitrectomy and whose axial length is more than 27mm |
Related Information
| Primary Sponsor | Iwase Takeshi |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Takeshi Iwase |
| Address | Akita University,1-1-1,Hondo, Akita Akita Japan 010-8543 |
| Telephone | +81-188846167 |
| tiwase@med.akita-u.ac.jp | |
| Affiliation | Akita University Hospital |
| Scientific contact | |
| Name | Takeshi Iwase |
| Address | Akita University,1-1-1,Hondo, Akita Akita Japan 010-8543 |
| Telephone | +81-188846167 |
| tiwase@med.akita-u.ac.jp | |
| Affiliation | Akita University Hospital |